COVID-19 Bulletin 6/29/2020
New study suggests a lower immunity level in the community than the typically quoted 60%, gauged by antibody tests, may be sufficient to protect everyone from COVID-19, as new case numbers surge in southwestern US states. Read the bulletin here.
Norbert Gleicher, MD, leads CHR’s clinical and research efforts as Medical Director and Chief Scientist. A world-renowned specialist in reproductive endocrinology, Dr. Gleicher has published hundreds of peer-reviewed papers and lectured globally while keeping an active clinical career focused on ovarian aging, immunological issues and other difficult cases of infertility.
We have helped women bring over 17,800 babies into the world.Discover your treatment options
- What is new regarding COVID-19? Most of the COVID-19 news these days is positive: new infections in the U.S. and countries, like Israel, have been declining rapidly and, with its deaths from the disease. At the same time, the news in big parts of the world, especially Europe and Brazil, is not that favorable.
- PGT-A, costly and unreliable yet marketed vigorously [PR]Dr. Gleicher joins two prominent colleagues in warning against the widespread utilization of PGT-A, in an opinion paper just published
- IVF Add-Ons: Scientific, Ethical, Regulatory, and Legal ConsiderationsHarvard University's Petrie-Flom Center is hosing a webinar on IVF add-ons on November 10, 2020 at noon EST. Dr. Gleicher
- SRBT Basic Science Award for a CHR AbstractOne of CHR's abstracts accepted to this year's ASRM meeting won the prestigious SRBT Basic Science Award. Read about Dr.